Clinical trial
Aranesp® Monthly Preference Study - 2
NCT00117078 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00117078 |
|---|---|
| Title | Aranesp® Monthly Preference Study - 2 |
| Official title | Aranesp® Monthly Preference Study - 2 |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Disease |
| Intervention type | Drug |
| Interventions | Aranesp® |
| First posted | Jul 4, 2005 |
| Last update posted | Sep 30, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: